TMDX
TransMedics Group Inc
NASDAQ: TMDX · HEALTHCARE · MEDICAL DEVICES
$92.00
-0.01% today
Updated 2026-11-12
Market cap
$3.16B
P/E ratio
24.78
P/S ratio
4.34x
EPS (TTM)
$3.67
Dividend yield
—
52W range
$60 – $156
Volume
1.0M
TransMedics Group Inc (TMDX) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$92.00
12-Month target
$121.88
2030 Target
—
Intrinsic (DCF)
$304.76
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0.0B | $0.1B | $0.2B | $0.4B | $0.6B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 24.78x (capped 25x) · Margin: 19.90%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.